About Theragenics (NYSE:TGX)
Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two business segments: surgical products segment and brachytherapy seed segment. The Company's surgical products business manufactures, markets and sells disposable devices primarily utilized in certain surgical procedures. The Company's brachytherapy seed business manufactures, markets and sells radioactive seeds primarily utilized in the treatment of early stage prostate cancer. The Company designs , manufactures, assembles, packages and distributes its surgical products in three primary production facilities, each of which manufactures different products. In October 2013, the Company announced that it has completed the merger with Juniper Acquisition Corporation.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSE:TGX
CUSIPN/A
Phone+1-770-8315137
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Theragenics (NYSE:TGX) Frequently Asked Questions
What is Theragenics' stock symbol?
Theragenics trades on the New York Stock Exchange (NYSE) under the ticker symbol "TGX."
Has Theragenics been receiving favorable news coverage?
News coverage about TGX stock has trended positive this week, Accern Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Theragenics earned a coverage optimism score of 0.35 on Accern's scale. They also gave news stories about the medical device company an impact score of 48.19 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
How do I buy shares of Theragenics?
Shares of TGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Theragenics' stock price today?
One share of TGX stock can currently be purchased for approximately $0.0050.
How can I contact Theragenics?
Theragenics' mailing address is 5203 Bristol Industrial Way, BUFORD, GA 30518, United States. The medical device company can be reached via phone at +1-770-8315137.
MarketBeat Community Rating for Theragenics (TGX)
MarketBeat's community ratings are surveys of what our community members think about Theragenics and other stocks. Vote "Outperform" if you believe TGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TGX will underperform the S&P 500 over the long term. You may vote once every thirty days.
Theragenics (NYSE:TGX) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/25/2016 forward)
Theragenics (NYSE:TGX) Earnings History and Estimates Chart
Theragenics (NYSE TGX) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/8/2013 | Q2 2013 | | $0.03 | $21.96 million | $20.30 million | View | N/A |  |
| 2/14/2013 | Q4 2012 | | ($0.01) | $19.88 million | $19.10 million | View | Listen | |
| 11/8/2012 | Q312 | | $0.02 | $20.50 million | $19.92 million | View | N/A | |
| 8/9/2012 | Q2 2012 | | $0.02 | | | View | N/A | |
| 5/10/2012 | Q1 2012 | | $0.03 | | | View | N/A | |
| 2/23/2012 | Q4 2011 | | $0.01 | | | View | N/A | |
| 11/3/2011 | Q3 2011 | $0.02 | $0.03 | | | View | N/A | |
| 8/11/2011 | Q2 2011 | $0.01 | $0.04 | | | View | N/A | |
| 5/5/2011 | Q1 2011 | $0.01 | $0.02 | | | View | N/A | |
| 2/15/2011 | Q4 2010 | | $0.03 | | | View | N/A | |
| 11/9/2010 | Q3 2010 | $0.03 | $0.03 | | | View | N/A | |
| 8/10/2010 | Q2 2010 | $0.01 | $0.02 | | | View | N/A | |
| 5/4/2010 | Q1 2010 | $0.01 | $0.02 | | | View | N/A | |
| 2/11/2010 | Q4 2009 | | $0.01 | | | View | N/A | |
| 11/5/2009 | Q3 2009 | | $0.02 | | | View | N/A | |
| 8/6/2009 | Q2 2009 | | $0.04 | | | View | N/A | |
| 5/7/2009 | Q1 2009 | | $0.02 | | | View | N/A | |
| 2/19/2009 | Q4 2008 | | $0.01 | | | View | N/A | |
| 10/30/2008 | Q3 2008 | | $0.03 | | | View | N/A | |
| 7/31/2008 | Q2 2008 | | $0.05 | | | View | N/A | |
| 5/1/2008 | Q1 2008 | | $0.05 | | | View | N/A | |
| 2/7/2008 | Q4 2007 | | $0.03 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Theragenics (NYSE:TGX) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Theragenics (NYSE TGX) Insider Trading and Institutional Ownership History
Theragenics (NYSE TGX) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Theragenics (NYSE TGX) News Headlines
| Source: |
|
No headlines for this company have been tracked by MarketBeat.com
Theragenics (NYSE:TGX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Theragenics (NYSE:TGX) Income Statement, Balance Sheet and Cash Flow Statement
Theragenics (NYSE TGX) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
